验证数据展示
经过测试的应用
Positive WB detected in | mouse small intestine tissue, rat small intestine tissue |
Positive IHC detected in | human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:1000-1:6000 |
Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 2 publications below |
IHC | See 2 publications below |
产品信息
12849-2-AP targets Galectin 2 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
经测试应用 | WB, IHC, ELISA Application Description |
文献引用应用 | WB, IHC |
经测试反应性 | human, mouse, rat |
文献引用反应性 | human |
免疫原 | Galectin 2 fusion protein Ag3979 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | lectin, galactoside-binding, soluble, 2 |
别名 | Gal 2, Galectin 2, HL14, Lactose binding lectin 2, LGALS2, S Lac lectin 2 |
计算分子量 | 132 aa, 15 kDa |
观测分子量 | 15 kDa |
GenBank蛋白编号 | BC029063 |
基因名称 | Galectin 2 |
Gene ID (NCBI) | 3957 |
RRID | AB_2136753 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | P05162 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
实验方案
Product Specific Protocols | |
---|---|
WB protocol for Galectin 2 antibody 12849-2-AP | Download protocol |
IHC protocol for Galectin 2 antibody 12849-2-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Oncotarget Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin. | ||
J Gastroenterol Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer. | ||
Oncotarget Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets. |